Literature DB >> 16525151

Sildenafil citrate therapy for pulmonary arterial hypertension.

Marius M Hoeper, Tobias Welte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525151     DOI: 10.1056/NEJMc053442

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

Review 2.  Cardiac manifestations in systemic sclerosis.

Authors:  Sevdalina Lambova
Journal:  World J Cardiol       Date:  2014-09-26

Review 3.  Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.

Authors:  Keshava Rajagopal; Andrew J Bryant; Sandeep Sahay; Nancy Wareing; Yang Zhou; Lavannya M Pandit; Harry Karmouty-Quintana
Journal:  Br J Pharmacol       Date:  2020-04-07       Impact factor: 8.739

Review 4.  The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension.

Authors:  Jeremy A Falk; Kiran J Philip; Ernst R Schwarz
Journal:  Vasc Health Risk Manag       Date:  2010-05-06

5.  Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.

Authors:  Corey E Ventetuolo; R Graham Barr; David A Bluemke; Aditya Jain; Joseph A C Delaney; W Gregory Hundley; Joao A C Lima; Steven M Kawut
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 6.  Sildenafil in the treatment of pulmonary hypertension.

Authors:  Christopher F Barnett; Roberto F Machado
Journal:  Vasc Health Risk Manag       Date:  2006

Review 7.  Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review.

Authors:  Mohammad Hassan Nezafati; Ali Eshraghi; Mohammad Vojdanparast; Saeed Abtahi; Pouya Nezafati
Journal:  J Res Med Sci       Date:  2016-09-01       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.